Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody

Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis

(2013) Bryan D. Choi et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody

(2013) B. D. Choi et al.   Cancer Immunology Research

An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma

(2013) Patrick C Gedeon et al.   Expert Review of Clinical Pharmacology

A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system

(2013) Bryan D. Choi et al.   OncoImmunology

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

(2012) B. D. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bispecific antibodies engage T cells for antitumor immunotherapy

(2011) Bryan D Choi et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

(2009) Bryan D. Choi et al.   BRAIN PATHOLOGY